Rapport Therapeutics (RAPP) Assets Average (2024 - 2026)

Rapport Therapeutics (RAPP) has 3 years of Assets Average data on file, last reported at $505.0 million in Q1 2026.

• Assets Average for Q1 2026 came in at $505.0 million, up 63.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $505.0 million (up 63.7% YoY), and the FY2025 annual result was $413.7 million, up 75.9% from the prior year.
• Assets Average retreated to $505.0 million in Q1 2026 per RAPP's latest filing, from $523.9 million in the prior quarter.
• Over five years, Assets Average peaked at $523.9 million in Q4 2025 and troughed at $293.8 million in Q2 2025.
• A 3-year average of $386.2 million and a median of $338.6 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2025 and 2026: Assets Average advanced 21.2% in 2025, then surged 63.7% in 2026.
• A 3-year view of Assets Average shows it stood at $323.0 million in 2024, then soared by 62.17% to $523.9 million in 2025, then declined by 3.6% to $505.0 million in 2026.
• Business Quant data shows RAPP's Assets Average at $505.0 million in Q1 2026, $523.9 million in Q4 2025, and $410.4 million in Q3 2025.